01—Abstract
Summary
Summary of the 8-K filed February 7, 2024. Cited figures are marked; the original filing is the authoritative source.
On February 7, 2024, Cencora, Inc. closed an underwritten public offering of $500 milliona of 5.125% Senior Notes due February 15, 2034, issued under a 2009 base indenture with U.S. Bank as trustee and a Twelfth Supplemental Indenture.
The notes are unsecured and rank equally with the company's other unsecured senior debt, but they are structurally subordinated to all liabilities of its subsidiaries, including trade payables. Interest is paid semiannually beginning August 15, 2024. The company can redeem the notes at a make-whole price before November 15, 2033 and at par thereafter.
Upon a change of control, holders can require repurchase at 101%b of principal. The primary purpose of the offering is refinancing. Management intends to use the net proceeds to redeem all of its 3.400% Senior Notes due May 15, 2024, with any remaining proceeds going to general corporate purposes.
The filing does not say whether the new notes are a net increase in total debt, so investors should check the balance sheet in the next periodic report. The indenture includes customary covenants that limit liens, sale-leaseback transactions, and mergers or asset sales of all or substantially all assets. Events of default include nonpayment, covenant breaches, cross-defaults, unpaid final judgments, and bankruptcy-type events, and acceleration can be triggered by holders of at least 25%c of outstanding principal.
For investors, this is a routine debt-management event rather than a change in strategy. It extends the company's maturity profile by roughly a decade at a fixed 5.125%d coupon, and it retires near-term 2024 maturities.
The filing contains no financial results, guidance, or operational updates. Its forward-looking statements point to the risk factors and MD&A in the fiscal 2023 Form 10-K, which covers the year ended September 30, 2023.
02—Key points
Key Highlights
- Cencora closed a $500 million offering of 5.125% Senior Notes due February 15, 2034 on February 7, 2024.
- Net proceeds are earmarked to redeem all of the company's 3.400% Senior Notes due May 15, 2024, with any remainder used for general corporate purposes.
- The notes are unsecured and rank pari passu with existing unsecured debt, but are structurally subordinated to all subsidiary liabilities, including trade payables.
- Redemption: make-whole call before November 15, 2033, and par call on or after that date, plus accrued interest in both cases.
- A change of control triggers an offer to repurchase at 101% of principal, plus accrued interest.
- Covenants restrict liens, sale-leaseback transactions, and mergers or sales of all or substantially all assets, subject to exceptions.
- The filing contains no earnings, guidance, or operating results; it is a financing event only.
03—Questions
Frequently Asked Questions
What is the new debt and what does it cost?
Cencora issued $500 million of 5.125% Senior Notes due February 15, 2034. Interest is paid semiannually on February 15 and August 15, starting August 15, 2024.
Why did Cencora issue these notes?
The company plans to use the net proceeds to redeem all of its 3.400% Senior Notes due May 15, 2024, and to apply any remaining proceeds to general corporate purposes. This is mainly a refinancing that pushes out near-term maturities.
How do the notes rank relative to other company debt?
The notes are unsecured and rank equally with all of Cencora's existing and future unsecured debt. They are structurally subordinated to all liabilities of the company's subsidiaries, so holders would be paid after subsidiary creditors from subsidiary assets.
Can Cencora repay the notes early, and are there investor protections?
Yes. The company can redeem the notes at a make-whole price before November 15, 2033, and at par plus accrued interest on or after that date. If a change of control occurs, Cencora must offer to repurchase the notes at 101% of principal, plus accrued interest, subject to certain limits.
Does this filing change Cencora's financial outlook?
No. The filing contains no updated financial results or guidance. It refers investors to the risk factors and MD&A in the fiscal 2023 Form 10-K (year ended September 30, 2023) for detailed risks and performance.
04—Continue